DULOXETINE HYDROCHLORIDE
| Brand name | DULOXETINE HYDROCHLORIDE |
|---|---|
| Active ingredient | DULOXETINE HYDROCHLORIDE |
| Strength | EQ 120MG BASE |
| Dosage form | CAPSULE, DELAYED REL PELLETS |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | February 2026 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12721817 | January 2046 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.